全事業営業利益又は全事業営業損失（△） - 医薬営業支援サービス、流動負債計
- 【期間】
| 年度 | 全事業営業利益又は全事業営業損失（△） - 医薬営業支援サービス | 流動負債計 |
|---|
| 2008/03 | - | | 3.13億 | |
| 2009/03 | - | | 4.13億 | +31.8% |
| 2010/03 | - | | 2.87億 | -30.7% |
| 2010/12 | - | | 2.83億 | -1.1% |
| 2011/03 | - | | 2.81億 | -0.8% |
| 2011/06 | - | | 2.4億 | -14.7% |
| 2011/09 | - | | 2.13億 | -11.1% |
| 2011/12 | - | | 2.41億 | +13.2% |
| 2012/03 | - | | 2.89億 | +19.6% |
| 2012/06 | - | | 2.72億 | -5.9% |
| 2012/09 | - | | 2.2億 | -19% |
| 2012/12 | - | | 2.13億 | -3.1% |
| 2013/03 | 4.63億 | | 2.62億 | +23% |
| 2013/06 | - | | 1.77億 | -32.7% |
| 2013/09 | - | | 1.79億 | +1.1% |
| 2013/12 | - | | 2.03億 | +13.6% |
| 2014/03 | 5.12億 | +10.6% | 2.12億 | +4.5% |
| 2014/06 | 0.72億 | -86% | 2.35億 | +10.8% |
| 2014/09 | 2.31億 | +220.8% | 2.5億 | +6.4% |
| 2014/12 | 5.38億 | +133.2% | 3.72億 | +48.9% |
| 2015/03 | 1.14億 | -78.9% | 6.81億 | +82.9% |
| 2015/06 | 2.13億 | +87.1% | 2.38億 | -65% |
| 2015/09 | 3.42億 | +60.7% | 5.45億 | +128.6% |
| 2015/12 | 5.57億 | +63% | 2.84億 | -48% |
| 2016/03 | 1.15億 | -79.4% | 5.37億 | +89.4% |
| 2016/06 | 2.44億 | +111.6% | 3.4億 | -36.6% |
| 2016/09 | 3.69億 | +51.5% | 6.21億 | +82.6% |
| 2016/12 | 6.7億 | +81.6% | 4.86億 | -21.7% |
| 2017/03 | 2.39億 | -64.4% | 6.72億 | +38.1% |
| 2017/06 | 3.99億 | +67.1% | 7.06億 | +5.1% |
| 2017/09 | 6.22億 | +55.9% | 8.1億 | +14.8% |
| 2017/12 | 9.46億 | +52.1% | 8.59億 | +6.1% |
| 2018/03 | 3.04億 | -67.8% | 6.94億 | -19.3% |
| 2018/06 | 5.13億 | +68.9% | 6.43億 | -7.3% |
| 2018/09 | 7.34億 | +43% | 6.07億 | -5.7% |
| 2018/12 | 11億 | +50% | 7.55億 | +24.5% |
| 2019/03 | 3.05億 | -72.3% | 5.78億 | -23.5% |
| 2019/06 | 5.94億 | +94.4% | 5.88億 | +1.7% |
| 2019/09 | 9.33億 | +57.1% | 5.51億 | -6.3% |
| 2019/12 | 14.8億 | +58.4% | 9.1億 | +65.1% |
| 2020/03 | 3.72億 | -74.8% | 16.9億 | +85.4% |
| 2020/06 | 8.13億 | +118.8% | 19.5億 | +15.3% |
| 2020/09 | 15.5億 | +90.9% | 20.7億 | +6.3% |
| 2020/12 | 26.7億 | +72% | 22.1億 | +6.9% |
| 2021/03 | - | | 15.6億 | -29.3% |
| 2021/06 | - | | 18.4億 | +17.6% |
| 2021/09 | - | | 16.8億 | -8.3% |
| 2021/12 | - | | 25.2億 | +49.6% |
| 2022/03 | - | | 16.1億 | -35.9% |
| 2022/06 | - | | 17.9億 | +11.1% |
| 2022/09 | - | | 16.9億 | -5.7% |
| 2022/12 | - | | 28.2億 | +66.9% |
| 2023/03 | - | | 19.5億 | -30.8% |
| 2023/06 | - | | 20.6億 | +5.3% |
| 2023/09 | - | | 17.1億 | -16.8% |
| 2023/12 | - | | 24.5億 | +43.1% |
| 2024/03 | - | | 20.9億 | -14.8% |
| 2024/06 | - | | 21.6億 | +3.4% |
| 2024/09 | - | | 19億 | -11.8% |
| 2024/12 | - | | 25.2億 | +32.3% |
| 2025/03 | - | | 21.1億 | -16.4% |
全事業営業利益又は全事業営業損失（△） - 医薬営業支援サービスその他推移
割合
